Safety and Efficacy Study of ABX-EGF in Patients With Renal Cancer, Part 2

Clinical trial NCT00425035 · COMPLETED

Trial details

NCT number: NCT00425035
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Renal Cell Carcinoma

Start date: 2003-02-01
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.